Xeriant

XERI

Aerospace & Defense · Industrials

Price

$0.01

+0.00 (+6.38%)

Market Cap

$13.9M

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Share count rising — dilution

+175.3% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 225.5M (2021) → 620.9M (2025)

Xeriant, Inc. is a small aerospace company focused on developing advanced aircraft and aviation technologies. The company works on next-generation aircraft concepts, including hybrid-electric and vertical takeoff and landing (eVTOL) vehicles. It operates in the emerging advanced air mobility space, partnering with other aerospace firms to bring new aircraft designs closer to reality.

Xeriant generates revenue through technology licensing, partnerships, and development agreements rather than selling finished aircraft. The company is based in the United States and is very early-stage, with a tiny market cap and deeply negative operating margins, meaning it spends far more than it earns. The main risk is that Xeriant has not yet proven it can scale a product to commercial viability, and it depends heavily on outside funding and partnerships to survive — a common challenge for pre-revenue aerospace startups competing against much larger, better-funded rivals.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+80.8% YoY

YoY Growth Rate

Strong earnings growth

R&D Spend

$69,274/ year

↓ Declining (-65% vs prior year)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

3.8%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~1 months

$44,850 cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Short runway — potential dilution ahead through share issuance

Cash watch

Xeriant has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

50.0%

Healthy — 50.0% gross margin

Operating Margin

-317.8%

Losing money on operations — -317.8%

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

-86%

Weak — only -86% of profit becomes cash

FCF Margin

-1381.8%

Burning cash (-1381.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

10.7x

Attractive valuation — P/E 10.7

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial